[1] |
韩鹏,汪钦,刘浩林,等.PCI 及CABG 治疗严重病变程度冠心病患者的临床效果比较[J].现代生物医学进展,2019,19(23):4445-4449.
|
[2] |
钱海燕,黄觊,马文健,等.冠状动脉血流储备分数位于灰区的老年冠心病患者不同治疗策略[J].中华老年医学杂志,2020,39(3):273-276.
|
[3] |
赵帅,王伟,汪钦,等.PCI 治疗对CTO 合并LVEF 降低的冠心病患者术后短期生活质量的影响[J].中国动脉硬化杂志,2019,27(7):593-598.
|
[4] |
吴尘乐.老年冠心病病人PCI 术中应用比伐卢定治疗的临床研究[J].中西医结合心脑血管病杂志,2019,17(12):1855-1857.
|
[5] |
邵利辉,王艳娟,李敏,等.PCI 术后早期康复对冠心病患者心脏康复的作用研究[J].心血管康复医学杂志,2019,28(5):571-575.
|
[6] |
De Bruyne B,Pijls NHJ,Kalesan B,et al.Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease[J].N Engl J Med,2012,367(11):991-1001.
|
[7] |
Zhang H,Chang R.Effects of exercise after percutaneous coronary intervention on cardiac function and cardiovascular adverse events in patients with coronary heart disease:systematic review and Meta-analysis[J].J Sports Sci Med,2019,18(2):213-222.
|
[8] |
国家卫生计生委合理用药专家委员会,中国药师协会.冠心病合理用药指南(第2 版)[J].中国医学前沿杂志(电子版),2018,10(6):1-130.
|
[9] |
吴国顺.N 末端B 型钠尿肽原与美国纽约心脏病学会心功能分级在心力衰竭诊断中的相关性对比分析[J].中国医药指南,2014,12(23):250-251.
|
[10] |
Dorje T,Zhao G,Scheer A,et al.SMARTphone and social media-based Cardiac Rehabilitation and Secondary Prevention (SMART-CR/SP) for patients with coronary heart disease in China:a randomised controlled trial protocol[J].BMJ Open,2018,8(6):e021908.
|
[11] |
Xia TL,Huang FY,Peng Y,et al.Efficacy of Different Types of Exercise-Based Cardiac Rehabilitation on Coronary Heart Disease:a Network Meta-analysis[J].J Gen Intern Med,2018,33(12):2201-2209.
|
[12] |
Figulla HR,Lauten A,Maier LS,et al.Percutaneous Coronary Intervention in Stable Coronary Heart Disease-Is Less More?[J].Dtsch Arztebl Int,2020,117(9):137-144.
|
[13] |
Xaplanteris P,Fournier S,Pijls NHJ,et al.Five-Year Outcomes with PCI Guided by Fractional Flow Reserve[J].N Engl J Med,2018,379(3):250-259.
|
[14] |
Jian W,Li L,Wei XM,et al.Prognostic value of angiopoietin-2 for patients with coronary heart disease after elective PCI[J].Medicine (Baltimore),2019,98(5):e14216.
|
[15] |
Wang YX,Wang XL,Wang JR,et al.Tongmai Yangxin intervening in myocardial remodeling after PCI for coronary heart disease:study protocol for a double-blind,randomized controlled trial[J].Trials,2020,21(1):287.
|
[16] |
Iqbal J,Serruys PW.Revascularization strategies for patients with stable coronary artery disease[J].J Intern Med,2014,276(4):336-351.
|
[17] |
Kang Q,Li XL,Yang MY,et al.Galectin-3 in patients with coronary heart disease and atrial fibrillation[J].Clin Chim Acta,2018,478:166-170.
|
[18] |
JCS Joint Working Group.Guidelines for diagnosis and treatment of patients with vasospastic angina (Coronary Spastic Angina) (JCS 2013)[J].Circ J,2014,78(11):2779-2801.
|